Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What Takeda's Failed TOMMORROW Trial Means For Early Alzheimer's Today

Executive Summary

The TOMMORROW study was revolutionary for its time in testing Actos early, before symptoms are apparent; failure is disappointing but similar metabolic approaches might still play a role, says the Alzheimer's Association.

Advertisement

Related Content

Private Longeveron Bets On Stem Cells For Inflammation, Aging Diseases
Pharmas Join To Build Inflammation Biomarkers In Alzheimer's, Depression
Continuing Dismay In Alzheimer's: vTv's RAGE Antagonist Fails In Phase III Study
Takeda Catches Rising Tide Of Antisense Neuroscience R&D
J.P. Morgan Notebook Day 2: Walmsley On Diversity, Amgen's Overseas Cash, Growing Opdivo, Mylan On US Generic Pricing, Boston's Pipeline And J&J In Alzheimer's
Deal Watch: As J.P. Morgan Waits For New Deals, Sanofi Takes Care Of Old Business
Disappointed, Yes, But Roivant's Not Roiled By Axovant's Alzheimer's Failure
Another Nail In Amyloid Hypothesis Coffin? Merck Ends Pivotal BACE Inhibitor Study
After Solanezumab, What’s Next? Alzheimer’s Options Take The Stage At CTAD
What to look out for at the Alzheimer's Association International Conference

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100271

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel